n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and madecassoside

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with madecassoside in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, B; Li, J; Li, Z; Wang, J; Wang, Y; Xu, H; You, K1

Other Studies

1 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and madecassoside

ArticleYear
Madecassoside suppresses proliferation and invasiveness of HGF-induced human hepatocellular carcinoma cells via PKC-cMET-ERK1/2-COX-2-PGE2 pathway.
    International immunopharmacology, 2016, Volume: 33

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Centella; Cyclooxygenase 2; Dinoprostone; Extracellular Signal-Regulated MAP Kinases; Hep G2 Cells; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Neoplasm Invasiveness; Nitrobenzenes; Protein Kinase C; Proto-Oncogene Proteins c-met; RNA, Small Interfering; Signal Transduction; Sulfonamides; Triterpenes

2016